Tang-Du Hospital: Lung Neoplasms trials

The registry lists 16 Lung Neoplasms studies with Tang-Du Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 3Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung CancerNot yet recruitingNCT06978153Phase 2
• This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete ResponseNot yet recruitingNCT06851169Phase 2
• Partial Pressure of Oxygen Control Method in Identification of Intersegmental PlaneRecruitingNCT06644066Not applicable
• A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLCNot yet recruitingNCT06503042
• Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized TrialRecruitingNCT06485544Phase 2
• Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLCNot yet recruitingNCT06475755Phase 2
• Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung CancerRecruitingNCT06467786Phase 4
• An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain MetastasisRecruitingNCT06352502
• A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLCStatus unknownNCT04840290Phase 3
• A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung CancerCompletedNCT03451526
• A Study to Explore Prognoses of NSCLC Patients Complicated With OligometastasesStatus unknownNCT03427541
• A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase InhibitorsStatus unknownNCT03424980
• Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung CancerStatus unknownNCT02622607Phase 3
• Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung AdenocarcinomaStatus unknownNCT02518802Phase 3
• Role of Bronchoscopy in Early Lung Cancer Screening of High Risk PopulationTerminatedNCT02277366
• Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy CombinationStatus unknownNCT02268162Not applicable